Federal Register: FDA Issues Request for Information, Establishment of a Public Docket on Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products
October 07, 2026
October 07, 2026
WASHINGTON, Oct. 7 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
The Food and Drug Administration (FDA) is describing the approaches it is considering for the design of early-phase clinical trials of ibogaine drug products and is opening a public d . . .
* * *
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
The Food and Drug Administration (FDA) is describing the approaches it is considering for the design of early-phase clinical trials of ibogaine drug products and is opening a public d . . .